BIIB - BIOGEN INC.
143.66
-7.050 -4.907%
Share volume: 1,838,069
Last Updated: 03-11-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.00%
PREVIOUS CLOSE
CHG
CHG%
$150.71
-7.05
-0.05%
View ratios
| Fiscal Date | 12-31-2023 | 12-31-2023 | 03-31-2024 | 03-31-2024 | 06-30-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2023 | Q4 2023 | Q1 2024 | Q1 2024 | Q2 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 02-12-2025 | 02-14-2024 | 04-24-2024 | 04-24-2024 | 08-01-2024 | 08-01-2024 | 10-30-2024 | 02-12-2025 | |
| Total revenue | 2.386 B | 2.386 B | 2.291 B | 2.291 B | 2.465 B | 2.465 B | 2.466 B | 2.455 B | |
| Cost of revenue | 618.300 M | 618.300 M | 542.200 M | 542.200 M | 546.000 M | 546.000 M | 638.700 M | 583.500 M | |
| Gross profit | 1.768 B | 1.768 B | 1.748 B | 1.748 B | 1.919 B | 1.919 B | 1.827 B | 1.871 B | |
| 0.00% | -1.11% | 0.00% | 9.76% | 0.00% | -4.78% | 2.41% | |||
| Operating expenses | 1.179 B | 1.179 B | 1.034 B | 1.034 B | 1.068 B | 1.068 B | 1.131 B | 1.212 B | |
| Selling general and admin | 608.500 M | 608.500 M | 581.500 M | 581.500 M | 553.800 M | 553.800 M | 588.400 M | 680.000 M | |
| Research and development | 570.900 M | 570.900 M | 452.900 M | 452.900 M | 513.900 M | 513.900 M | 542.700 M | 532.300 M | |
| Total expenses | 1.161 B | 1.929 B | 1.284 B | 1.721 B | 1.220 B | 1.763 B | 1.376 B | 1.236 B | |
| 66.13% | -33.45% | 34.05% | -29.08% | 44.48% | -21.95% | -10.17% | |||
| Operating income | 607.100 M | 457.700 M | 464.800 M | 570.000 M | 698.700 M | 701.900 M | 451.000 M | 635.100 M | |
| Ebit | 607.100 M | 457.700 M | 464.800 M | 570.000 M | 698.700 M | 701.900 M | 451.000 M | 635.100 M | |
| Pretax income | 291.600 M | 291.600 M | 464.800 M | 464.800 M | 698.700 M | 698.700 M | 451.000 M | 291.500 M | |
| 0.00% | 59.40% | 0.00% | 50.32% | 0.00% | -35.45% | -35.37% | |||
| Income tax | 42.700 M | 42.700 M | 71.400 M | 71.400 M | 115.100 M | 115.100 M | 62.500 M | 24.800 M | |
| Net income basic | 0.000 | 249.700 M | 0.000 | 393.400 M | 0.000 | 583.600 M | 0.000 | 0.000 | |
| -100.00% | -100.00% | -100.00% | |||||||
| Net income | 248.900 M | 249.700 M | 393.400 M | 393.400 M | 583.600 M | 583.600 M | 388.500 M | 266.700 M | |
| 0.32% | 57.55% | 0.00% | 48.35% | 0.00% | -33.43% | -31.35% |